China Medical University Hospital (CMUH) Triapin Listing
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the reduction in office seated systolic blood
pressure (BP) following a 8 weeks regimen of ramipril 5mg plus felodipine 5mg versus ramipril
10mg.
To compare the response rate (defined as office systolic blood pressure (SBP) / Diastolic
blood pressure (DBP) reduce more than 10mmHg from baseline), and BP controlled rate (defined
as SBP<140mmHg and/or DBP<90mmHg) and as SBP < 130 mmHg and /or DBP < 80 mmHg in
diabetes,chronic kidney disease, known Coronary Arterial Disease (CAD) or CAD equivalent, or
10-year Framingham risk score > 10%.
To ascertain the safety and tolerability of ramipril/felodipine versus ramipril in Taiwanese
population.
To compare compliance with fixed dose combination of ramipril/felodipine versus ramipril
treatment.